Dr. Rizvi Discusses Pembrolizumab for Non-Small Cell Lung Cancer
1 Views
administrator
07/14/23
Naiyer A. Rizvi, MD, an associate attending physician, Memorial Sloan Kettering Cancer Center, discusses pembrolizumab (MK-3475) for the treatment of non-small cell lung cancer (NSCLC).
-
Category
Show more
Facebook Comments
No comments found